CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

74 hedge funds and large institutions have $110M invested in Cascadian Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
22
Reduced
19
Closed
7
Calls
$2.27M
Puts
$722K
Net Calls
+$1.54M
Net Calls Change
-$53K
Name Holding Trade Value Shares
Change
Shares
Change %
HCM
76
Highlander Capital Management
New Jersey
-$11.4K -1,083 Closed